Found 2917 clinical trials
C2541013 MIRNA NASH
is specifically designed to evaluate the effect of a range of doses of DGAT2i alone, and DGAT2i + ACCi, on resolution of NASH or improvement in liver fibrosis, as assessed histologically (via liver
- 314 views
- 31 Aug, 2021
- 62 locations
Non-Alcoholic Fatty Liver Disease
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-alcoholic Fatty Liver Disease (NAFLD) - A radomized, doubleblind, placebo-controlled
- 15 views
- 25 Jan, 2021
- 1 location
TREATMENT OF LIVER FIBROSIS IN ADULTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
NASH IS LIVER INFLAMMATION AND DAMAGE CAUSED BY A BUILDUP OF FAT IN THE LIVER.
- 93 views
- 03 Oct, 2019
- 1 location
AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer
AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer
- 400 views
- 07 Nov, 2020
- 1 location
NASH (Nonalcoholic Steatohepatitis)
Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. ClinSearch is enrolling volunteers with a condition called liver fibrosis from NASH
- 35 views
- 23 Nov, 2020
- 1 location
The AURORA Study
Assessing the efficacy and safety of Cenicriviroc for the treatment of liver fibrosis in adults with non-alcoholic steatohepatitis (NASH)
- 295 views
- 23 Nov, 2020
- 1 location
BLOOD SAMPLE COLLECTION- UNTREATED MELANOMA
MELANOMA, ALSO KNOWN AS MALIGNANT MELANOMA, IS A TYPE OF CANCER THAT DEVELOPS FROM THE PIGMENT-CONTAINING CELLS KNOWN AS MELANOCYTESUP OF FAT IN THE LIVER.
- 13 views
- 03 Oct, 2019
- 1 location
NASH
FATTY LIVER OR NASH? Learn more about a clinical research study for individuals with NASH.Insurance is not needed to participate in this study.
- 1 views
- 04 Mar, 2021
- 1 location
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
obsessions and compulsions. The study drug also has better oral bioavailability, no food restrictions, lower overall burden to the liver, reduced pharmacokinetic variability, and only has to be dosed once
- 0 views
- 05 Apr, 2021
- 1 location
A Pilot Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
SLL Age greater than or equal to 18 years Not pregnant or breast-feeding women Adequate kidney and liver function Study Design:
- 69 views
- 15 Apr, 2019
- 1 location